CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
Champions Oncology Q4 Earnings Call Highlights
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock
Champions Oncology Reports Record Annual Revenue of $59 Million
Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript
Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate
Zacks Initiates Coverage of Champions Oncology With Neutral Recommendation
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ...
Champions Oncology (CSBR) Earnings Transcript
Champions Oncology, Inc. Q3 2026 Earnings Call Summary
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss
Champions Oncology Reports Revenue of $16.6 Million
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
Champions Oncology Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $16.559M Miss $16.613M Estimate
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.